0001415889-24-011482.txt : 20240424
0001415889-24-011482.hdr.sgml : 20240424
20240424185425
ACCESSION NUMBER: 0001415889-24-011482
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240422
FILED AS OF DATE: 20240424
DATE AS OF CHANGE: 20240424
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Howell Michael
CENTRAL INDEX KEY: 0001970231
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40598
FILM NUMBER: 24872281
MAIL ADDRESS:
STREET 1: 4225 EXECUTIVE SQUARE
STREET 2: SUITE 600
CITY: LA JOLLA
STATE: CA
ZIP: 92037
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Zura Bio Ltd
CENTRAL INDEX KEY: 0001855644
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4225 EXECUTIVE SQUARE
STREET 2: SUITE 600
CITY: LA JOLLA
STATE: CA
ZIP: 92037
BUSINESS PHONE: 858-247-0520
MAIL ADDRESS:
STREET 1: 4225 EXECUTIVE SQUARE
STREET 2: SUITE 600
CITY: LA JOLLA
STATE: CA
ZIP: 92037
FORMER COMPANY:
FORMER CONFORMED NAME: JATT Acquisition Corp
DATE OF NAME CHANGE: 20210407
4
1
form4-04242024_100418.xml
X0508
4
2024-04-22
0001855644
Zura Bio Ltd
ZURA
0001970231
Howell Michael
C/O 4225 EXECUTIVE SQUARE, SUITE 600
LA JOLLA
CA
92037
false
true
false
false
See Remarks
0
Class A ordinary shares
2024-04-22
4
P
0
7987
3.13
A
7987
I
By corporation
Class A ordinary shares
114395
D
These shares were acquired in a private placement transaction pursuant to the terms of that certain Securities Purchase Agreement, dated as of April 18, 2024, between the Issuer and Mountaineer Biosciences, Inc. ("Mountaineer") at a purchase price of $3.13 per share.
These shares are beneficially owned by Mountaineer. The Reporting Person is the Co-Founder of Mountaineer and, as such, has the power to vote and dispose of the ordinary shares held by Mountaineer. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
/s/ Michael Howell
2024-04-24